Three arm Y-shaped bisbiotin ligand

Patent metadata

Field	Value
Publication number	US-10156572-B2
Application number	US-201515119549-A
Country	US
Kind code	B2
Filing date	Feb 18, 2015
Priority date	Feb 18, 2014
Publication date	Dec 18, 2018
Grant date	Dec 18, 2018

Abstract

Embodiments of the present disclosure provide bisbiotin ligands and related conjugates and methods. The bisbiotin ligands, combined with streptavidin, can be used in the separation, labelling, targeting, and immobilization of biomolecules.

First claim

The invention claimed is:

1. A ligand comprising a multiplicity of biotin moieties, wherein each biotin moiety is attached to a rigid, nano-meter central core through a flexible linker, wherein the ligand presents at least two biotin moieties to a target, and wherein the at least two biotin moieties are attached to a trilinker having the following structure:

wherein n is 1 to 50.

2. The ligand of claim 1 , wherein the target is streptavidin.

3. The ligand of claim 1 , wherein n is 6.

4. The ligand of claim 1 , wherein the ligand has the following structure

5. The ligand of claim 1 , wherein the ligand is conjugated to a moiety selected from the group consisting of: a fluorescent tag, a quantum dot, a redox reagent, a magnetic nanoparticle, and a gold nanoparticle.

6. The ligand of claim 5 , wherein the ligand has the following structure

7. The ligand of claim 1 , wherein the ligand is immobilized to an atomic force microscopy tip.

8. The ligand of claim 7 , wherein the ligand is connected to the atomic force microscopy tip via a PEG linker.

9. The ligand of claim 1 , wherein the ligand is attached to a nanoparticle functionalized with alkynes through a reaction between the azide on the ligand and the alkynes.

10. A method for the separation and detection of biomolecules in a biological sample, the method comprising:
immobilizing streptavidin to the ligand of claim 9 via streptavidin-biotin interaction;
attaching one or more biotinylated probes or affinity molecules to the streptavidin to form a streptavidin/biotin nanoparticle complex, wherein the one or more biotinylated probes or affinity molecules are capable of binding to the biomolecules in the biological sample;
incubating the nanoparticle complex with the biological sample under conditions to allow the one or more biotinylated probes or affinity molecules to bind to the biomolecules in the biological sample;
separating the biomolecules bound to the nanoparticle complex from the biological sample; and
detecting the binding of biomolecules to the nanoparticle complex.

11. The method of claim 10 , wherein the biomolecule is selected from the group consisting of DNA, RNA, proteins, and peptides.

12. The method of claim 10 , wherein the probes are DNA probes or RNA probes.

13. The method of claim 10 , wherein the affinity molecules are one or more of antibodies, aptamers, or peptides.

14. The ligand of claim 1 , further comprising a thiol group at a non-biotin moiety region of the ligand.

15. The ligand of claim 1 , having the following structure:

16. A monolayer comprising a plurality of the ligands of claim 14 immobilized on a gold substrate.

17. The monolayer of claim 16 , wherein the monolayer further comprises an alkylated PEG spacer.

Assignees

• Univ Arizona State

Inventors

• Zhang Peiming
• Lindsay Stuart
• Senapati Subhadip
• Biswas Sudipta

Classifications

• G01Q60/38

  Probes, their manufacture, or their related instrumentation, e.g. holders · CPC title

• C12Q1/6816

  characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

• G01N33/587 Primary

  Nanoparticles · CPC title

• C12Q1/6834

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C07C247/04

  being saturated · CPC title